Format

Send to

Choose Destination
Eur J Nucl Med Mol Imaging. 2020 Mar 4. doi: 10.1007/s00259-020-04742-w. [Epub ahead of print]

Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant.

Author information

1
Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany. henryk.barthel@medizin.uni-leipzig.de.
2
Department of Nuclear Medicine, University of Navarra Clinic, Pamplona, Spain.
3
Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
4
German Centre for Neurodegenerative Diseases, Bonn-Cologne, Germany.
5
Molecular Organization of the Brain, Research Centre Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
6
Division of Nuclear Medicine and Molecular Imaging, Geneva University, Geneva, Switzerland.
7
VUMC Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
8
Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
PMID:
32130450
DOI:
10.1007/s00259-020-04742-w

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center